A new study by drugmaker GlaxoSmithKline has found that Advair (fluticasone propionate, salmeterol) and Flovent (fluticasone propionate) appear to be safe for adults with asthma to use twice a day. Researchers found that both drugs were well tolerated when patients used them twice-daily during a 4-week trial, with no reports of serious side effects.
Read moreA cure for asthma is not likely. That's the bad news. The good news is that asthma deaths have decreased and advances in... Read more »
Asthma control is possible for most people who have asthma. That means you can expect to live an active life without being bothered by... Read more »
While the economy sputters, the long acting bronchodilator/ corticosteroid combination inhaler market is booming. While big ... Read more »
Last week, the Food and Drug Administration (FDA) listened to presentations and comments from several members of an expert FDA advisory... Read more »
This is a study to compare the effects of Flovent (fluticasone propionate), Advair (fluticasone propionate/salmeterol), and Singulair (montelukast)... Read more »
This is a study to measure the asthma control of Flovent (fluticasone propionate) and salmeterol in children and teens whose asthma is worsened by... Read more »
Patients whose asthma is not controlled by taking fluticasone propionate (Flovent) alone may benefit from taking antileukotriene drugs with the... Read more »
GlaxoSmithKline is conducting a clinical trial to see if fluticasone propionate plus salmeterol (Advair) is better than fluticase propionate alone... Read more »
Have questions or comments? Click here. Last week the Food and Drug Administration (FDA) listened to presentations and comments from several members... Read more »